A multicenter, retrospective study evaluating antifungal prophylaxis of Posaconazole in Acute Myeloid Leukemia and Myelodysplastic Syndrome Patients Treated with Intensive Chemotherapy

Trial Profile

A multicenter, retrospective study evaluating antifungal prophylaxis of Posaconazole in Acute Myeloid Leukemia and Myelodysplastic Syndrome Patients Treated with Intensive Chemotherapy

Completed
Phase of Trial: Phase IV

Latest Information Update: 03 Aug 2015

At a glance

  • Drugs Posaconazole (Primary)
  • Indications Mycoses
  • Focus Adverse reactions; Therapeutic Use
  • Most Recent Events

    • 03 Aug 2015 New trial record
    • 14 Jun 2015 Results presented at the 20th Congress of the European Haematology Association.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top